Bayer Aktiengesellschaft (BIT:1BAYN)
Italy
· Delayed Price · Currency is EUR 26.80
+0.83 (3.20%)
Last updated: Aug 13, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Crop Science | 22.26B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Crop Science Growth | -5.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals | 18.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Growth | 0.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Health | 5.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Health Growth | 0.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Enabling Functions and Consolidation | 19.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Enabling Functions and Consolidation Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Other Segment | 327.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Other Segment Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Crop Science Adjusted EBITDA | 4.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Crop Science Adjusted EBITDA Growth | -4.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Adjusted EBITDA | 4.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Adjusted EBITDA Growth | -11.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Health Adjusted EBITDA | 1.37B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consumer Health Adjusted EBITDA Growth | 3.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Enabling Functions and Consolidation Adjusted EBITDA | -352.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Enabling Functions and Consolidation Adjusted EBITDA Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Other Segment Adjusted EBITDA | 62.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Other Segment Adjusted EBITDA Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Europe/Middle East/Africa | 13.98B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe/Middle East/Africa Growth | -3.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | 16.48B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | 1.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia/Pacific | 8.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia/Pacific Growth | 1.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Latin America | 8.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Latin America Growth | -10.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|